Skip to main content

Shenyang Xingqi Pharmaceutical

Shenyang Xingqi Pharmaceutical Co Ltd, operating as Xingqi Eye Medicine, is a Chinese pharmaceutical enterprise specializing in the research, development, manufacturing, and sale of ophthalmic prescription drugs. The company formulates and manufactures eye drops, eye gels, and ocular ointments covering dry eye disease, ocular inflammation, glaucoma, and myopia control, including low-concentration atropine eye drops. Revenue is principally generated through direct product sales of prescription ophthalmic drugs to pharmaceutical wholesalers, clinical hospital networks, and retail pharmacies across China. Core end markets encompass ophthalmology specialty clinics, hospital eye departments, retail pharmacies, and myopia control patients in Mainland China. Xingqi Eye Medicine holds a market-leading position in China's domestic ophthalmic prescription drug industry. The company is headquartered in Shenyang, China, and its common shares trade on the ChiNext board of the Shenzhen Stock Exchange.

2 of the funds FundTelligence covers report a position in Shenyang Xingqi Pharmaceutical.

Legal name
Shenyang Xingqi Pharmaceutical Co Ltd
Sector
Health Care
Country
China
Funds holding it
2

Funds holding Shenyang Xingqi Pharmaceutical

Loading...